Nurturing and extending connections among regional innovation stakeholders is at the core of BioRN's activities. We therefore rely for example on different events formats to bridge members regionally and towards other innovative ecosystems worldwide.
Julia Schaft, Managing Director of BioRN joint the Boehringer Ingelheim Academy Panel Discussion at BI Innovation Prize reception at BioLabs Heidelberg [more]
The new BioRN Espresso series kicked off on March 14th with the topic: "Battle for talents – boost your recruiting strategy with perfect match and positive psychology". The panellists Thomas Winter, Genius Search Heidelberg and Linda Kirchner, YUMAB GmbH gave insights and discussed with the audience about the do´s and don´ts to attract candidates despite the tense situation on the job market [more].
Andreas Schmidt, Senior Vice President Global Business Development talked with BioRN about the one-stop-shop solution for single cell multi-omics sequencing at Singleron Biotechnologies at the M2M - Member to Member event [more]
BioRN hosted on March 15, 2023 in Heidelberg a ‘Stammtisch’ with OCCIDENT, an international venture capital investor with offices in Zug and Munich, with the motivation to establish trusted connections within innovation ecosystems as early possible [more].
Enjoy the news from our network and mark your calendar for the upcoming events!
Annalisa Zuccotti
Events & Communication Lead
BioRN Life Science Cluster Rhine-Neckar
01 | Research Highlights & News
02 | New Members
03 | Events Spotlight
04 | Event Calendar & Discounts
05 | Open Positions
01| Research Highlights & News
Ardigen and DKFZ research groups are entering into a collaboration to evaluate the safety of TCR-based therapies (TCR-Ts)[more]
BIO Deutschland: Strengthening Germany as a location for innovation, biotechnology and pharmaceuticals, securing EU funds, joining IPCEI Health[more]
DKFZ:
High honor for pioneers of cancer immunotherapy: Meyenburg Prize 2020/21 goes to Katalin Karikó, Uǧur Șahin and Özlem Türeci [more]
Marker for therapy response in acute myeloid leukemia (AML) identified [more]
Gut Microbiome Plays Key Role in Response to CAR-T Cell Cancer Immunotherapy [more]
AI and multispectral imaging facilitate keyhole surgery [more]
New functions discovered for wellknown cancer driver [more]
DIVERSA Technologies and BioCat agreement marks new milestone in internationalization thanks to new service BiointeRNational [more]
Standard BioTools: Four experts share their image analysis tools and key insights[more]
10x Genomics:
Bacterial single cell RNA-seq reveals antibiotic resistance mechanisms [more]
Spatial transcriptomics—the next evolution of cancer drug discovery [more]
02 | New Members
The Rhine-Neckar-District is one of the best places to live and work in Germany: Businesses value the excellent infrastructure of the district situated between two riv-ers as well as the proximity to the universities of Mannheim and Heidelberg, which provide them with a well-qualified workforce. Many attractive employers are situated here –hidden champions from the small and medium-sized business sector as well as global players.
Entrepreneurs and start-ups profit from active business development, sound know-how of the subsidy environment, and of course the open-mindedness and creativity of the local population.
Tcelltech GmbH is a German clinical-stage, biotechnology company developing immunotherapies to cure cancer. The company was founded as a spin-off from DKFZ Heidelberg in 2022.
Tcelltech's lead product “UNIPACT” is a personalized T-cell therapy with large therapeutic potential against multiple cancers. Tcelltech’s UNIPACT leverages two technology platforms:
(I) The AI-based bioinformatics platform IMPACT that allows for rapid tumor reactive T-cell receptor identification (II) The novel non-viral gene delivery vector system “nanoSMAR”
03 | Events Spotlight
04 | Event Calendar & Discounts
Regulatory Approaches in Novel Technologies and Methods April 11, 2023 - Amsterdam (NL) & Online >>
Partner with Bayer, let's Collaborate To Cure! April 20, 2023 - Online >>
BioVaria 2023 April 24-25, 2023 - Munich, Germany >>
Swiss Biotech Day 2023 April 24-25, 2023 - Basel, Switzerland >>
Reduced registration fee for BioRN members
European Pharma Days April 25-26, 2023 - Mannheim, Germany >>
4C Close up – Insights into C2 | Requirements engineering & good product development April 25, 2023 - Online >>
You are currently viewing a placeholder content from Mailchimp. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
